Brain-heart Interaction in Coronary Plaque Stability and Cardiovascular Events
Blueprint
Biological Interconnection of Brain Neurobiological Activity With Atherosclerotic Plaque Vulnerability and the Prognostic Value
1 other identifier
observational
300
1 country
4
Brief Summary
The effect of brain-heart interaction remains unclear. The study aims to investigate the biological interconnection between brain neural activity and coronary plaque morphological and inflammatory features, as well as their connection with clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 15, 2022
CompletedFirst Posted
Study publicly available on registry
September 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedSeptember 19, 2022
September 1, 2022
7.8 years
September 15, 2022
September 15, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Correlation Between amygdalar activity (neurobiological activity) and bone marrow hematopoiesis (hematopoietic activity)
Amygdalar target-to-background ratio (TBR) = Amygdalar standardized uptake value (SUV) / Temporal lobe SUV Bone marrow TBR = Bone marrow SUV / Jugular vein SUV Correlation between amygdalar activity (neurobiological activity) and bone marrow hematopoiesis (hematopoietic activity) will be assessed
at the index imaging
Correlation Between amygdalar activity (neurobiological activity) and high-risk plaque
High-risk plaque features will be assessed by CCTA including positive remodeling (PR, defined as lesion diameter/reference diameter ≥1.1), low attenuation plaque (LAP, defined as a focal central area of plaque with an attenuation density of \<30 Hounsfield Units), spotty calcification (SC, defined as focal calcification within the coronary artery wall \<3mm in maximum diameter), and the "napkin ring" sign (defined as a central area of low attenuation plaque that had a peripheral rim of high attenuation). Correlation Between amygdalar activity and number of high-risk plaque features will be assessed.
at the index imaging
Correlation Between amygdalar activity (neurobiological activity) and coronary inflammation
Coronary inflammation will be assessed by FAI. Correlation Between amygdalar activity and FAI will be assessed
at the index imaging
Major adverse cardiac events
Death from coronary heart disease, nonfatal myocardial infarction or hospitalization for unstable angina.
5 years after index imaging
Secondary Outcomes (1)
Cardiovascular death, or nonfatal myocardial infarction
5 years after index imaging
Study Arms (1)
CCTA imaging with 18F-FDG-PET/CT assessment
Group of patients with 18F-FDG-PET/CT imaging and Coronary Computed Tomographic Angiography within 90 days
Interventions
18F-FDG-PET/CT imaging and comprehensive assessment of coronary plaque with CCTA within 90 days
Eligibility Criteria
Patients who underwent clinically indicated 18F-FDG PET/CT and with CCTA performed within 90 days of 18F-FDG PET/CT scan will be included.
You may qualify if:
- \) Age: greater than 20
- \) Patients either absence of prior cancer or remission from cancer for at least 1 year prior to imaging and throughout the follow-up period;
- \) Patients absence of acute or chronic inflammatory or autoimmune disease at the time of imaging;
- \) Patients with CCTA performed within 90 days of 18F-FDG PET/CT scan as part of routine clinical practice
- \) Patients with diameter stenosis \>30% by CCTA but without coronary revascularization
You may not qualify if:
- \) Complex coronary lesion (ostial lesion, unprotected left main lesion, chronic total occlusion, grafted vessels, etc)
- \) Coronary lesion with heavy calcification
- \) Chronic renal insufficiency (Serum creatinine \>2.0mg/dL)
- \) Severe liver dysfunction (aspartate transaminase or alanine transferase \> 5 times of upper normal limit)
- \) Pregnancy or potential pregnancy
- \) Life expectancy less than 5 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Fuwai Hospital
Beijing, 200000, China
Shanghai Zhongshan Hospital
Shanghai, 200032, China
Shanghai Tenth People's Hospital
Shanghai, China
Universal Medical Imaging Diagnostic
Shanghai, China
Related Publications (3)
Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, Pitman RK. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet. 2017 Feb 25;389(10071):834-845. doi: 10.1016/S0140-6736(16)31714-7. Epub 2017 Jan 12.
PMID: 28088338BACKGROUNDTawakol A, Osborne MT, Wang Y, Hammed B, Tung B, Patrich T, Oberfeld B, Ishai A, Shin LM, Nahrendorf M, Warner ET, Wasfy J, Fayad ZA, Koenen K, Ridker PM, Pitman RK, Armstrong KA. Stress-Associated Neurobiological Pathway Linking Socioeconomic Disparities to Cardiovascular Disease. J Am Coll Cardiol. 2019 Jul 2;73(25):3243-3255. doi: 10.1016/j.jacc.2019.04.042.
PMID: 31248544BACKGROUNDDai N, Tang X, Weng X, Cai H, Zhuang J, Yang G, Zhou F, Wu P, Liu B, Duan S, Yu Y, Guo W, Ju Z, Zhang L, Wang Z, Wang Y, Lu B, Shi H, Qian J, Ge J. Sex Differences in Coronary Inflammation and Atherosclerosis Phenotypes in Response to Imaging Marker of Stress-Related Neural Activity. Circ Cardiovasc Imaging. 2024 Feb;17(2):e016057. doi: 10.1161/CIRCIMAGING.123.016057. Epub 2024 Feb 20.
PMID: 38377235DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Junbo Ge, Professor
Fudan University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2022
First Posted
September 19, 2022
Study Start
January 1, 2015
Primary Completion
October 30, 2022
Study Completion
December 30, 2022
Last Updated
September 19, 2022
Record last verified: 2022-09